avoid like plague
back fire
credit crunch
competition emerge
cold hearted
caught surprise
decline United States
decline demand
decrease earnings
dead money
earning miss
miss earning
earning decline
decline earning
fall cliff
gone nowhere
hard hearted
high risk
increase short interest
increased operating expenditure
limited upside
low confidence
lower target
negative publicity
negative earnings
overpriced
price gouging
price slip
pull back
reflect badly
raised concern
rejected marketing authorization
sales decreased
sales miss
stay away
significant risk
specialty pharmacy
state budgets
unsustainable
value trap
weak pipeline



